Vascular Biogenics Ltd.

Vascular Biogenics Ltd.verified

VBLT

Price:

$0.156

Market Cap:

$12.11M

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal c...[Read more]

Industry

Biotechnology

IPO Date

2014-10-01

Stock Exchange

NASDAQ

Ticker

VBLT

The PE Ratio as of July 2024 (TTM) for Vascular Biogenics Ltd. (VBLT) is -0.87

According to Vascular Biogenics Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.87. This represents a change of 301.46% compared to the average of -0.22 of the last 4 quarters.

Vascular Biogenics Ltd. (VBLT) Historical PE Ratio (quarterly & annually)

How has VBLT PE Ratio performed in the past?

The mean historical PE Ratio of Vascular Biogenics Ltd. over the last ten years is -5.54. The current -0.87 PE Ratio has changed 1.46% with respect to the historical average. Over the past ten years (40 quarters), VBLT's PE Ratio was at its highest in in the December 2017 quarter at 8.15. The PE Ratio was at its lowest in in the June 2014 quarter at -12.84.

Quarterly (TTM)
Annual

Average

-5.54

Median

-4.07

Minimum

-19.46

Maximum

-0.29

Vascular Biogenics Ltd. (VBLT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vascular Biogenics Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 275.57%

Maximum Annual PE Ratio = -0.29

Minimum Annual Increase = -93.93%

Minimum Annual PE Ratio = -19.46

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.29-93.93%
2021-4.7640.24%
2020-3.3955.76%
2019-2.1839.32%
2018-1.56-91.97%
2017-19.46157.10%
2016-7.575.47%
2015-7.18275.57%
2014-1.91-73.14%
2013-7.11-29.62%

Vascular Biogenics Ltd. (VBLT) Average PE Ratio

How has VBLT PE Ratio performed in the past?

The current PE Ratio of Vascular Biogenics Ltd. (VBLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.81

5-year avg

-2.44

10-year avg

-5.54

Vascular Biogenics Ltd. (VBLT) PE Ratio vs. Peers

How is VBLT’s PE Ratio compared to its peers?

Vascular Biogenics Ltd.’s PE Ratio is less than Revelation Biosciences, Inc. (-0.20), greater than Zura Bio Limited (-3.18), greater than Phio Pharmaceuticals Corp. (-2.20), less than ZyVersa Therapeutics, Inc. (-0.02), less than TransCode Therapeutics, Inc. (-0.25), less than Panbela Therapeutics, Inc. (0), less than Virax Biolabs Group Limited (-0.04), less than Allarity Therapeutics, Inc. (-0.30), less than ContraFect Corporation (-0.00), less than Avenue Therapeutics, Inc. (-0.11), less than Acumen Pharmaceuticals, Inc. (-0.27), greater than HOOKIPA Pharma Inc. (-3.07), greater than Day One Biopharmaceuticals, Inc. (-16.94), greater than Inozyme Pharma, Inc. (-6.21), greater than Terns Pharmaceuticals, Inc. (-4.27), greater than X4 Pharmaceuticals, Inc. (-6.93), greater than Galera Therapeutics, Inc. (-1.18), less than null (-0.15),

Build a custom stock screener for Vascular Biogenics Ltd. (VBLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vascular Biogenics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vascular Biogenics Ltd. (VBLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vascular Biogenics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Vascular Biogenics Ltd.'s PE Ratio?

How is the PE Ratio calculated for Vascular Biogenics Ltd. (VBLT)?

What is the highest PE Ratio for Vascular Biogenics Ltd. (VBLT)?

What is the 3-year average PE Ratio for Vascular Biogenics Ltd. (VBLT)?

What is the 5-year average PE Ratio for Vascular Biogenics Ltd. (VBLT)?

How does the current PE Ratio for Vascular Biogenics Ltd. (VBLT) compare to its historical average?